ID   DEAF1_RAT               Reviewed;         565 AA.
AC   O88450; Q62998;
DT   13-AUG-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   27-MAR-2024, entry version 144.
DE   RecName: Full=Deformed epidermal autoregulatory factor 1 homolog;
DE   AltName: Full=Nuclear DEAF-1-related transcriptional regulator;
DE            Short=NUDR;
DE   AltName: Full=Suppressin;
GN   Name=Deaf1; Synonyms=Spn;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=Sprague-Dawley; TISSUE=Testis;
RX   PubMed=9773984; DOI=10.1210/mend.12.10.0181;
RA   Huggenvik J.I., Michelson R.J., Collard M.W., Ziemba A.J., Gurley P.,
RA   Mowen K.A.;
RT   "Characterization of a nuclear deformed epidermal autoregulatory factor-1
RT   (DEAF-1)-related (NUDR) transcriptional regulator protein.";
RL   Mol. Endocrinol. 12:1619-1639(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   STRAIN=Sprague-Dawley; TISSUE=Pituitary;
RX   PubMed=9417089; DOI=10.1074/jbc.273.1.361;
RA   LeBoeuf R.D., Ban E.M.H., Green M.M., Stone A.S., Propst S.M.,
RA   Blalock J.E., Tauber J.D.;
RT   "Molecular cloning, sequence analysis, expression, and tissue distribution
RT   of suppressin, a novel suppressor of cell cycle entry.";
RL   J. Biol. Chem. 273:361-368(1998).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-443 AND SER-448, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16641100; DOI=10.1073/pnas.0600895103;
RA   Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.;
RT   "Quantitative phosphoproteomics of vasopressin-sensitive renal cells:
RT   regulation of aquaporin-2 phosphorylation at two sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-176, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Transcription factor that binds to sequence with multiple
CC       copies of 5'-TTC[CG]G-3' present in its own promoter and that of the
CC       HNRPA2B1 gene. Down-regulates transcription of these genes. Binds to
CC       the retinoic acid response element (RARE) 5'-AGGGTTCACCGAAAGTTCA-3'.
CC       Activates the proenkephalin gene independently of promoter binding,
CC       probably through protein-protein interaction. When secreted, behaves as
CC       an inhibitor of cell proliferation, by arresting cells in the G0 or G1
CC       phase. Regulates epithelial cell proliferation and side-branching in
CC       the mammary gland. Required for neural tube closure and skeletal
CC       patterning. Controls the expression of peripheral tissue antigens in
CC       pancreatic lymph nodes. Transcriptional activator of EIF4G3. May also
CC       involved in behavior (By similarity). {ECO:0000250|UniProtKB:O75398,
CC       ECO:0000250|UniProtKB:Q9Z1T5}.
CC   -!- SUBUNIT: Homodimer (By similarity). Interacts with LMO4; LMO4 blocks
CC       export from nucleus. Interacts with LMO2 and CLIM2. May interact with
CC       the corepressors NCOR1 and NCRO2. Identified in a complex with XRCC5
CC       and XRCC6. Interacts (via the SAND domain) with the DNA-PK complex
CC       subunit XRCC6; the interaction is direct and may be inhibited by DNA-
CC       binding (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Secreted. Note=Secreted in some cell
CC       types.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O88450-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O88450-2; Sequence=VSP_005969;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Detected in brain, spleen, adrenal,
CC       lung, skeletal muscle, liver, kidney, and in developing germ cells in
CC       testis. In pituitary, restricted to hormone-secreting cell types.
CC   -!- PTM: May be phosphorylated by DNA-PK complex in a DNA independent
CC       manner (in vitro). {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF055884; AAC79679.1; -; mRNA.
DR   EMBL; U59659; AAC35994.1; -; mRNA.
DR   AlphaFoldDB; O88450; -.
DR   BMRB; O88450; -.
DR   SMR; O88450; -.
DR   IntAct; O88450; 1.
DR   STRING; 10116.ENSRNOP00000046656; -.
DR   iPTMnet; O88450; -.
DR   PhosphoSitePlus; O88450; -.
DR   PaxDb; 10116-ENSRNOP00000046656; -.
DR   Ensembl; ENSRNOT00055050870; ENSRNOP00055041912; ENSRNOG00055029351. [O88450-1]
DR   Ensembl; ENSRNOT00060057360; ENSRNOP00060047393; ENSRNOG00060033065. [O88450-1]
DR   Ensembl; ENSRNOT00065032518; ENSRNOP00065025950; ENSRNOG00065019323. [O88450-1]
DR   UCSC; RGD:620671; rat. [O88450-1]
DR   AGR; RGD:620671; -.
DR   RGD; 620671; Deaf1.
DR   eggNOG; KOG4333; Eukaryota.
DR   InParanoid; O88450; -.
DR   PhylomeDB; O88450; -.
DR   PRO; PR:O88450; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; ISO:RGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0001662; P:behavioral fear response; ISO:RGD.
DR   GO; GO:0048706; P:embryonic skeletal system development; ISS:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0001843; P:neural tube closure; ISS:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:RGD.
DR   GO; GO:0033599; P:regulation of mammary gland epithelial cell proliferation; ISS:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0008542; P:visual learning; ISO:RGD.
DR   Gene3D; 6.10.140.2220; -; 1.
DR   Gene3D; 3.10.390.10; SAND domain-like; 1.
DR   InterPro; IPR010919; SAND-like_dom_sf.
DR   InterPro; IPR000770; SAND_dom.
DR   InterPro; IPR002893; Znf_MYND.
DR   PANTHER; PTHR10237:SF13; DEFORMED EPIDERMAL AUTOREGULATORY FACTOR 1 HOMOLOG; 1.
DR   PANTHER; PTHR10237; DEFORMED EPIDERMAL AUTOREGULATORY FACTOR 1 HOMOLOG SUPPRESSIN; 1.
DR   Pfam; PF01342; SAND; 1.
DR   Pfam; PF01753; zf-MYND; 1.
DR   SMART; SM00258; SAND; 1.
DR   SUPFAM; SSF144232; HIT/MYND zinc finger-like; 1.
DR   SUPFAM; SSF63763; SAND domain-like; 1.
DR   PROSITE; PS50864; SAND; 1.
DR   PROSITE; PS01360; ZF_MYND_1; 1.
DR   PROSITE; PS50865; ZF_MYND_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Developmental protein; DNA-binding; Metal-binding;
KW   Neurogenesis; Nucleus; Phosphoprotein; Reference proteome; Secreted;
KW   Transcription; Transcription regulation; Zinc; Zinc-finger.
FT   CHAIN           1..565
FT                   /note="Deformed epidermal autoregulatory factor 1 homolog"
FT                   /id="PRO_0000074087"
FT   DOMAIN          193..273
FT                   /note="SAND"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00185"
FT   ZN_FING         504..540
FT                   /note="MYND-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00134"
FT   REGION          29..62
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          162..189
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          403..478
FT                   /note="Interaction with LMO4"
FT                   /evidence="ECO:0000250"
FT   MOTIF           301..316
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        40..54
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         504
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00134"
FT   BINDING         507
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00134"
FT   BINDING         515
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00134"
FT   BINDING         518
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00134"
FT   BINDING         524
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00134"
FT   BINDING         528
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00134"
FT   BINDING         536
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00134"
FT   BINDING         540
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00134"
FT   MOD_RES         171
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z1T5"
FT   MOD_RES         176
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         179
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z1T5"
FT   MOD_RES         432
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O75398"
FT   MOD_RES         443
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         448
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   VAR_SEQ         1..68
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9417089"
FT                   /id="VSP_005969"
FT   CONFLICT        151
FT                   /note="V -> D (in Ref. 2; AAC35994)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        182
FT                   /note="A -> T (in Ref. 2; AAC35994)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        297..298
FT                   /note="FV -> LL (in Ref. 2; AAC35994)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        308..313
FT                   /note="ELPTTP -> VSCPRL (in Ref. 2; AAC35994)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        338..349
FT                   /note="SGQITTSGALTF -> FRTDHYLWSTNL (in Ref. 2; AAC35994)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        384..386
FT                   /note="PCR -> LQ (in Ref. 2; AAC35994)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        428
FT                   /note="V -> A (in Ref. 2; AAC35994)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        508
FT                   /note="G -> R (in Ref. 2; AAC35994)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        532
FT                   /note="D -> V (in Ref. 2; AAC35994)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   565 AA;  59532 MW;  D9C730E80A3F8492 CRC64;
     MEDSDSAAKQ LGLAEAAAVA AAAAVAAAAA AAAESEAEEP VLSRDEDSEE DADSEAERET
     RRVTAVAVMA AESGHMDMGT EALPSPDEAA AAAAFAEVTT VTVANVGSSA DNVFTTSVAN
     AASISGHVLS GRTALQIGDS LNTEKATLIV VHTDGSIVET TGLKGPAAPL TPGPQSPPTP
     LAPGQEKGGT KYNWDPSVYD SELPVRCRNI SGTLYKSRLG SGGRGRCIKQ GENWYSPTEF
     EAMAGRASSK DWKRSIRYAG RPLQCLIQDG ILNPHAASCT CAACCDDMTL SGPVRLFVPY
     KRRKKENELP TTPVKKDSPK NITLLPATAA TTFTVTPSGQ ITTSGALTFD RASTVEATAV
     ISESPAQGDV FAGATVQEAG VQPPCRVGHP EPHYPGYQDS CQIAPFPEAA LPTSHPKIVL
     TSLPALAVPP STPTKAVSPT VVSGLEMSEH RSWLYLEEMV NSLLNTAQQL KTLFEQAKQA
     SSCREAAVTQ ARMQVDAERK EQSCVNCGRE AMSECTGCHK VNYCSTFCQR KDWKDHQHVC
     GQSASVTVQA DDVHVEESVI EKVAV
//
